Filanesib TFA

Filanesib (ARRY-520) is a selective inhibitor of the mitotic kinesin KSP (Eg5), which induces mitotic arrest and apoptosis in proliferating cancer cells. Its research applications include investigating cell cycle mechanisms in vitro and evaluating antitumor efficacy in xenograft models, as documented in oncology and pharmacology studies.